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Ethnopharmacological relevance: The leaves of Hancornia speciosa Gomes are traditionally used to treat
diabetes in Brazil. The aim of the study is to evaluate the potential anti-diabetic effect of Hancornia
speciosa extract and derived fractions.
Materials and Methods: The ethanolic extract from Hancornia speciosa leaves and chromatographic
fractions thereof were evaluated on α-glucosidase assay, on hyperglycemic effect and glucose uptake. The
chemical composition of the extract and its most active fraction was investigated by ESI–LC–MS.
Results: The ethanolic extract and derived fractions inhibited α-glucosidase in vitro. However, only the
crude extract and the dichloromethane fraction inhibited the hyperglycemic effect induced by starch or
glucose. Both the extract and dichloromethane fraction were also able to increase glucose uptake in
adipocytes. Bornesitol, quinic acid, and chorogenic acid were identiﬁed in the extract, along with
ﬂavonoid glycosides, whereas the dichloromethane fraction is majorly composed by esters of lupeol and/
or α/β-amirin.
Conclusions: Hancornia speciosa has a potential anti-diabetic effect through a mechanism dependent on
inhibition of α-glucosidase and increase on glucose uptake. These results give support to the use on
traditional medicine of this medicinal plant.
& 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Diabetes is deﬁned as a metabolic disorder characterized by
chronic hyperglycemia with disturbances of protein and fat
metabolism resulting from defects in insulin secretion, insulin
action, or both (WHO, 2013). Diabetes type 2 is the most frequent
and has been evolved into a global epidemic (WHO, 2013).
Despite the great number of hypoglycemic drugs available, most
of them exhibit undesirable side effects, high cost and ultimately
cannot efﬁciently control alone the glycemia (Hung et al., 2012),
unless if associated with the adoption of lifestyle measures, such as
physical activity, control of a healthy body weight, avoid smoking
and maintenance of a healthy diet (WHO, 2013).
Several plant species are traditionally used as anti-diabetic
around the world and some of them have had their efﬁcacy
corroborated by pre-clinical and clinical assays (Hung et al., 2012;
Chang et al., 2013; Mata et al., 2013). Hancornia speciosa Gomes
(Apocynaceae), popularly known as mangabeira or mangaba, is a
tree widely distributed in the Cerrado biome from Brazil. It is
traditionally used as anti-diabetic, as anti-hypertensive and to treat
obesity (Hirschmann and de Arias, 1990; Rodrigues and Carvalho,
2001; Macedo and Ferreira, 2004). The potential anti-hypertensive,
chemopreventive, antioxidant and anti-inﬂammatory effects of
Hancornia speciosa have been consistently demonstrated by our
research group (Ferreira et al., 2007a; Ferreira et al., 2007b;
Endringer et al., 2009; Endringer et al., 2010; Silva et al., 2011).
The lack of a scientiﬁc report supporting the large use of this
plant for the treatment of diabetes led us to investigate the
potential anti-diabetic effect of Hancornia speciosa using in vitro
and in vivo methods.
2. Material and methods
2.1. Preparation of the extract and fractions
The leaves of Hancornia speciosa were furnished by Empresa
Estadual de Pesquisa Agropecuária da Paraíba (EMEPA), João Pessoa,
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Brazil. The vegetal material was collected in April 2009 from the
Active Germplasm Bank of Mangaba (BAG-Mangaba) in João Pessoa
(geographic coordinates: 61 33' 13" S and 341 48' 31" W; altitude of
30 m). After drying at 40 1C for 72 h, the plant material was
powdered (100 g) and percolated with 96% ethanol to afford a green
dark residue (EEH, 23.45 g) after solvent elimination under reduced
pressure. A portion of EEH (20 g) was submitted to chromatography
on a silica gel 60 (0.2–5 mm) column (33060 mm2 i.d.) eluted with
solvents of increasing polarity. After solvent elimination in a rotatory
evaporator, the n-hexane (0.031 g), DCM (1.198 g), DCM/EtOAc; (1:1)
(1.252 g), EtOAc (0.108 g), EtOAc/MeOH; (1:1) (16.0 g) and MeOH
(0.827 g) fractions were obtained.
2.2. α-glucosidase inhibition assay in vitro
The inhibitory activity against α-glucosidase was carried out
spectrophotometrically in a 96-well microplate reader as previously
described (Pereira et al., 2012a). A reaction mixture containing 0.04 U/
mL of enzyme, sample (0.3–1000 mg/mL) and 0.1 mM of reduced
glutathione was preincubated for 15min. The reaction was started by
the addition of 0.85mM p-nitrophenyl-α-D-glucopyranoside (pNPG) as
substrate. After 25min incubation at 37 1C, sodium carbonate was
added to stop the reaction. Absorbance readings were recorded at
405 nm (Thermoplate Reader, USA). Samples were dissolved in DMSO
and other reagents in 0.1 mM phosphate buffer pH 6.8. Acarbose (0.1–
100 ng/mL) was used as a reference drug. The inhibitory effect was
expressed as a percentage of inhibition related to the control.
2.3. Glucose uptake assay
Adipocytes were isolated from epididymal fat pads by the
method of Rodbell (1964). After isolation, adipocytes were incu-
bated with EEH and DCM (100 mg/mL) and insulin (50 ng/mL) for
45 min. The uptake of 2-deoxy-[3H]glucose was used to determine
the rate of glucose transport as previously described (Green, 1987).
Brieﬂy, glucose uptake was initiated by the addition of 2-deoxy-
[3H]glucose (0.2 mCi/tube) for 3 min. Thereafter, cells were sepa-
rated by centrifugation through silicone oil and cell-associated
radioactivity was determined by scintillation counting.
2.4. Animals
Animal experimental protocols conformed international guide-
lines and were approved by the local ethics committee [protocol
163/2010, UFMG]. Male Swiss mice (10–12 week old) were main-
tained with free access to standard diet (Nuvilab, Brazil) and tap
water was supplied ad libitum, at a constant temperature (237
2 1C), with a 12:12 h dark/light cycle. All experiments were carried
out using at least ﬁve animals per group.
2.5. Acute effect of EEH and its fractions on blood glucose in mice
The indirect evaluation of α-glucosidase inhibition in animals
was performed after cornstarch overload. Swiss mice were
deprived of food for 6 h before the test but allowed free access
of tap water throughout the experiment. Blood samples were
collected from the tail tip before EEH and fractions administration
(time 0). EEH, fractions, and cornstarch were administrated orally.
EEH and fractions (300 mg/kg) were dissolved in 50% labrasol.
After 20 min, cornstarch (2 g/kg) was administrated, and blood
samples were collected at 15, 30, 60 and 120 min after starch
overload. Acarbose (10 mg/kg) was used as a reference drug.
In order to evaluate the mechanism of action of the samples, the
glucose tolerance test was performed as described above, except
that glucose replaced cornstarch and glibenclamide (5 mg/kg)
replaced acarbose as reference drug.
2.6. Drugs
Unless otherwise mentioned, all reagents were purchased from
Sigma-Aldrich. Blood glucose concentration was determined with
an Accu-Chek active glucose meter (Roche Diagnostics, Brazil).
Labrasol was purchased from Gatefossé SAS (France).
2.7. Statistical analysis
The percentage of α-glucosidase inhibition was evaluated using
the pIC50 ( log of the sample concentration that inhibits activity
of the enzyme by 50%), which was calculated using non-linear
regression curve and expressed as mean7S.E.M.. Two-way or
one-way ANOVA analysis followed by the Bonferroni post-test
were employed, and signiﬁcance was accepted at Po0.05.
2.8. Chemical characterization of EEH and DCM by ESI–LC–MS
The chemical composition of EEH and DCM was analyzed using
an Acquity UPLC system (Waters, Milford, USA) with a Photodiode
Array (PDA) detector and interfaced to a triple quadrupole mass
spectrometer (TQD) (Waters Micromass, Manchester, UK). The
analyses were carried out on a reverse phase column (Acquity
UPLC BEH C18, Waters, Ireland; 502.1 mm2 i.d., 1.7 mm) in
combination with a guard column (Acquity UPLC BEH C18 Van-
Guard pre-column, Waters, Ireland; 2.15 mm2 i.d., 1.7 mm), using
a gradient elution of water (A) and acetonitrile (B), both containing
0.1% v/v formic acid (5–95% B in 10 min; 95–5% B in 1 min, followed
by 2 min of isocratic elution), at a ﬂow rate of 0.3 mL/min, and
temperature of 40 1C. Sample volume injected was 3 mL for EEH
(2 mg/mL) and 5 mL for DCM (5 mg/mL), both prepared as MeOH
solutions. For the ESI (negative and positive mode) source, the
following inlet conditions were applied: capillary voltage 3.54 kV;
cone voltage 17 V; source temperature 120 1C; desolvation tem-
perature 300 1C. The mass range was set at m/z 100–2000.
3. Results and discussion
Inhibition of α-glucosidase has been proven to be a valid
therapeutic option for the prevention of type 2 diabetes (Chiasson
et al., 2002). In the present study, the effect of EEH and its deri-
ved chromatographic fractions on α-glucosidase were evaluated
in vitro (Fig. 1). EEH, DCM, DCM:EtOAc, EtOAc, EtOAc:MeOH and
MeOH fractions promoted a concentration-dependent inhibition of
α-glucosidase activity (Fig. 1A) with similar potency, excepting
EtOAc, which showed a lower pIC50 value (Fig. 1B). The small
yielding of the hexane fraction did not allow us to perform the test
with α-glucosidase. Considering the difference of polarity among
the fractions and the crude extract, the obtained results suggest
that the different classes of compounds may account for the
α-glucosidase inhibition. The idea of a broad class of natural
products as inhibitors of α-glucosidase is compatible with reports
from the literature (Reddy et al., 2009; Bräunlich et al., 2013).
L-bornesitol, quinic acid, and rutin were previously reported in an
ethanol extract from Hancornia speciosa leaves (Endringer et al.,
2009). In our experimental conditions, L-bornesitol did not inhibit
α-glucosidase (data not shown). Quinic acid and rutin derivatives
are well-known inhibitors of α-glucosidase (Iwai et al., 2006;
Pereira et al., 2011), and probably contribute to the observed effect.
Moreover, chemical studies with Hancornia speciosa leaves have
also indicated the presence of terpenoids, steroids and tannins
(Honda et al., 1990; Brandão et al., 2011), which could also play a
role in the inhibitory effect of this plant on α-glucosidase.
The starch tolerance test demonstrated that EEH, DCM, and
MeOH fractions were able to decrease the plasma concentration of
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glucose in mice (Fig. 2 A and B). The strongest reduction was
observed with DCM, being similar to the reduction induced by
acarbose in 60 min (Fig. 2B). The lowest effect was observed with
MeOH, whereas EtOAc induced no signiﬁcant reduction in the
plasmatic glucose (Fig. 2B). Therefore, these in vivo results are
compatible with the inhibitory effect of EEH, DCM and MeOH on
Fig. 1. Inhibitory effect of Hancornia speciosa crude ethanolic extract (EEH) and its dichloromethane (DCM), ethyl acetate (EtOAc), DCM:EtOAc, methanolic (MeOH) and
EtOAc:MeOH fractions on α-glucosidase. (A) Concentration–response curves for EEH, DCM, EtOAc and MeOH (0.3–1000 mg/mL). (B) pIC50 values for EEH, DCM, DCM:EtOAc,
EtOAc, EtOAc:MeOH, MeOH and acarbose. Data represent mean7S.E.M.
n
Po0.05 and nnnPo0.001 versus EEH data.
Fig. 2. Effect of Hancornia speciosa on the starch tolerance test, glucose tolerance test and glucose uptake. (A and B) Effect of 300 mg/kg of the ethanolic crude extract (EEH)
and its dichloromethane (DCM), ethyl acetate (EtOAc) and methanolic (MeOH) fractions on the starch tolerance test and (C) on the glucose tolerance test in mice. (D) Effect of
the EEH and DCM (100 mg/mL) and insulin (50 ng/mL) on glucose uptake in adipocytes. Data represent mean7S.E.M. n Po0.05, nnPo0.01 and nnnPo0.001 versus control or
basal data. yPo0.05 versus EEH and insulin.
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α-glucosidase, and the absence of effect for EtOAc might be
related with its lower potency, inability to cross the intestinal
mucosal barrier or low bioavailability. In order to minimize the
number of animals used the fractions DCM:EtOAc and EtOAc:
MeOH were not tested, considering that they had, respectively,
similar effect and potency as the EtOAc and MeOH fractions.
Fig. 3. ESI/LC–MS of selected peaks in the ethanolic extract from Hancornia speciosa leaves (A–C) and dichloromethane fraction thereof (D). Peaks: (A), quinic acid;
(B) bornesitol; (C) rutin; (D) ester of lupeol.
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Considering that cyclitols and ﬂavonoids, previously described in
EEH (Endringer, 2007; Pereira et al., 2012b) are able to reduce the
blood glucose by increasing the glucose uptake (Shen et al., 2012;
Babu et al., 2013). The effect of the crude extract (EEH) and its
most active fraction (DCM) were evaluated in the oral glucose
tolerance test. As illustrated in Fig. 2C, both EEH and DCM were
signiﬁcantly able to reduce the plasma concentration of glucose,
suggesting an additional effect of EEH and DCM on glucose
homeostasis. This additional effect was conﬁrmed when EEH and
DCM were tested against the glucose uptake in freshly dissociated
adipocytes, where both induced a signiﬁcant increase on glucose
uptake (Fig. 2D). It is noteworthy to observe that the effect induced
by EEH was similar to insulin while the effect of DCM was
signiﬁcantly smaller than EEH and insulin (Fig. 2D). Despite the
reduced effect of DCM on glucose uptake, its excellent reduction
on plasma glucose in the starch tolerance test suggest that the
effect of this fraction is more selective for the inhibition of α-
glucosidase.
Previous phytochemical studies of Hancornia speciosa leaves
resulted in the identiﬁcation of different classes of compounds,
including cyclitols [L-(þ)-bornesitol, quinic, 5-O-caffeoil-quinic and
chlorogenic acids], cynamic acids (cis- and trans-4-hydroxy-cynamic
acids), ﬂavonoids (kaempferol-3-O-rutinoside, rutin and a quercetin
triglycoside), steroids and triterpenes (β-sitosterol, obtusalin, eri-
throdiol and 3β-O-esters of lupeol, α- and β-amirin) (Endringer,
2007; Barros, 2008; Endringer et al., 2007; Endringer et al., 2009;
Pereira et al., 2012b).
Aiming to characterize the chemical composition of EEH and its
DCM fraction, they were analyzed by ESI–LC–MS, being the results
compared with reference compounds and/or the literature data
reported for the species. Hence, negative ion mode analysis of EEH
led to the detection of quinic acid (Rt¼0.51 min) by the peak at
m/z 191.4 [MH]– (Fig. 3) and chlorogenic acid (Rt¼1.91 min) at
m/z 353.6 [MH]–, along with rutin (Rt¼2.73 min), identiﬁed by
the peak at m/z 609.7 [MH]– (Fig. 3). Bornesitol (Rt¼0.53 min)
was disclosed by the peak of its sodium adduct at m/z 217.4
[Mþ23]þ in the positive ion mode analysis of EEH (Fig. 3).
In addition, the compound eluted at 3.04min gives a peak at m/z
593.7 [MH]– compatible with a kaempferol diglycoside, supported
by the fragment at m/z 447.7 [MH146]– resulting from the loss of
one sugar residue. On its turn, the constituent eluting at 3.60 minwas
ascribed to a kaempferol triglycoside, disclosed by the peak at m/z
755.6 [MH]–. The analysis also revealed lipophilic compounds,
whose MS data are compatible with esters of lupeol or α-/β-amirin.
The ﬁrst eluted at 6.49 min and gives a peak at m/z 471.8 [MHþ
46]– credited to the formic acid adduct of the triterpene (lupeol or
α-/β-amirin), along with a peak atm/z 311.7 [MH426.8]– assigned
to the side chain fragment (C19H36O3). The second ester eluted at
7.56 min and was suggested by the peak at m/z 339.7 [MH
426.8]–, attributed to the side chain residue (C21H40O3). In addition,
positive ion mode analysis of the compound eluting at 11.09 min
gives a peak at m/z 155.2 [MþH]þ , compatible with the volatiles
trans- and cis-linalool oxide, α-terpinol and geraniol.
HPLC and TLC analyses of DCM revealed majorly triterpenes
and derivatives as constituents of the fraction (data not shown), in
agreement with previous reports for the species (Endringer, 2007;
Barros, 2008). ESI–LC–MS analysis of DCM disclosed different
esters of lupeol or α/β-amirin as discussed above for EEH. For
instance, the compound eluting at 9.24 min showed a base peak at
m/z 471.8 [MHþ46]– ascribed to the adduct of lupeol with
formic acid, along with a fragment at m/z 339.7 [MH426.7]–
credited to the side chain residue (C21H40O3) (Fig. 3). The ESI–LC
data also revealed the presence of monoterpenes at m/z 155.2
[MþH]þ , similarly as found in EEH.
It is noteworthy that lupeol and α/β-amirin are well known as
anti-diabetic drugs (Ali et al., 2006; Santos et al., 2012). The
mechanism of action is better characterized for lupeol, as an
inhibitor of α-glucosidase and protein tyrosine phosphatase-1B
(Na et al., 2009; Nkobole et al., 2011). These reports from the
literature suggest that lupeol and α/β-amirin may contribute to
the anti-diabetic effect of Hancornia speciosa.
Altogether the present work demonstrates that Hancornia
speciosa reduces the blood glucose concentration through inhibi-
tion of intestinal α-glucosidase and stimulation of glucose uptake
by adipocytes. These results suggest the potential use of this plant
for the treatment of diabetes mellitus.
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